Arcadia Biosciences's total assets for Q3 2025 were $8.58M, an increase of 10.22% from the previous quarter. RKDA total liabilities were $3.14M for the fiscal quarter, a -3.50% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.